Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL209298 | 0.86 | — | — | |
| SCHEMBL10733816 | 0.78 | — | — | |
| SCHEMBL12326455 | 0.77 | PRKCA (0.34) | PRKCAELANE | |
| SCHEMBL11788330 | 0.74 | ELANE (0.34) | PRKCAELANE | |
| SCHEMBL15165 | 0.74 | TSHR (0.41) | PRKCAELANE | |
| SCHEMBL1141547 | 0.73 | ELANE (0.40) | PRKCAELANE | |
| Methyl Alcohol SCHEMBL28449343 | 0.72 | TSHR (0.40) | PRKCAELANE | |
| SCHEMBL7631957 | 0.72 | — | — | |
| SCHEMBL31516123 | 0.71 | ALDH1A1 (0.33) | PRKCA | |
| SCHEMBL1141230 | 0.71 | MMP8 (0.37) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | SUMITOMO CHEMICAL CO (JP) | 2026-01-01 | — | — | US | disclosed |
| EP-4578895-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578894-A1 | HYDROPHILIC OIL REPELLENT POLYMER | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-20230129965-A1 | HYDROPHILIC AND OLEOPHOBIC POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4130057-A1 | HYDROPHILIC OIL REPELLENT POLYMER | Sumitomo Chemical Company, Limited (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-111684019-B | Composition and molded article | 住友化学株式会社 | 2022-08-02 | — | — | CN | disclosed |
| EP-2824069-B1 | SURFACE-TREATED CARBON NANOTUBE AND RESIN COMPOSITION | ASAHI CHEMICAL IND (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-10479853-B2 | Surface-treated carbon nanotube and resin composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2019-11-19 | — | — | US | disclosed |
| US-20170130035-A1 | WAVELENGTH CONVERSION MATERIAL AND SOLAR CELL SEALING FILM CONTAINING THE SAME | BRIDGESTONE CORPORATION (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-2824069-A1 | SURFACE-TREATED CARBON NANOTUBE AND RESIN COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2015-01-14 | — | — | EP | disclosed |
| CN-1248339-C | Anode for nonaqueous electrolyte, its making method, battery with anode and its making method | SANYO ELECTRIC CO (JP) | 2006-03-29 | — | — | CN | disclosed |
| US-20030036488-A1 | Viscosity index improver and lube oil containing the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-02-20 | — | — | US | disclosed |
| CN-1262532-A | Anode for nonaqueous electrolyte, its making method, battery with anode and its making method | SANYO ELECTRIC CO (JP) | 2000-08-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479853-B2 | Surface-treated carbon nanotube and resin composition | ACTN1, CD63, ACTN4 | PRKCA 2582/4885ELANE 39/4885 |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | CCR1, H1-3, CCR3 | PRKCA 3548/4885ELANE 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.